GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Onward Medical NV (STU:63E) » Definitions » Additional Paid-In Capital

Onward Medical NV (STU:63E) Additional Paid-In Capital : €155.25 Mil(As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Onward Medical NV Additional Paid-In Capital?


Onward Medical NV's quarterly additional paid-in capital declined from Dec. 2022 (€155.25 Mil) to Jun. 2023 (€155.25 Mil) but then increased from Jun. 2023 (€155.25 Mil) to Dec. 2023 (€155.25 Mil).

Onward Medical NV's annual additional paid-in capital stayed the same from Dec. 2021 (€155.25 Mil) to Dec. 2022 (€155.25 Mil) and stayed the same from Dec. 2022 (€155.25 Mil) to Dec. 2023 (€155.25 Mil).


Onward Medical NV Additional Paid-In Capital Historical Data

The historical data trend for Onward Medical NV's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Onward Medical NV Additional Paid-In Capital Chart

Onward Medical NV Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Additional Paid-In Capital
Get a 7-Day Free Trial 3.08 3.08 155.25 155.25 155.25

Onward Medical NV Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Additional Paid-In Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only 155.25 155.25 155.25 155.25 155.25

Onward Medical NV Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)* Shares Outstanding (Diluted Average)

Onward Medical NV Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Onward Medical NV's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.


Onward Medical NV (STU:63E) Business Description

Traded in Other Exchanges
Address
High Tech Campus 32, Noord-Braban, Eindhoven, NH, NLD, NL-5656 AE
Onward Medical NV is a medical technology company developing and commercializing therapies to enable functional recovery for people with spinal cord injury. It has developed two programmable neurostimulation platforms: an implantable system, ARCIM, and a non-invasive, transcutaneous system, ARCEX. The company has selected the United states and four European markets: Germany, France, the UK and the Netherlands to create a customer base.

Onward Medical NV (STU:63E) Headlines

No Headlines